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In growing cells, DNA replication precedes mitotic cell division
to transmit genetic information to the next generation. The slow-
ing or stalling of DNA replication forks at natural or exogenous
obstacles causes “replicative stress” that promotes genomic insta-
bility and affects cellular fitness. Replicative stress phenotypes can
be characterized at the single-molecule level with DNA combing or
stretched DNA fibers, but interpreting the results obtained with
these approaches is complicated by the fact that the speed of repli-
cation forks is connected to the frequency of origin activation. Pri-
mary alterations in fork speed trigger secondary responses in ori-
gins, and, conversely, primary alterations in the number of active
origins induce compensatory changes in fork speed. Here, by
employing interventions that temporally restrict either fork speed
or origin firing while still allowing interrogation of the other vari-
able, we report a set of experimental conditions to separate cause
and effect in any manipulation that affects DNA replication
dynamics. Using HeLa cells and chemical inhibition of origin activ-
ity (through a CDC7 kinase inhibitor) and of DNA synthesis (via the
DNA polymerase inhibitor aphidicolin), we found that primary
effects of replicative stress on velocity of replisomes (fork rate) can
be readily distinguished from primary effects on origin firing. Iden-
tifying the primary cause of replicative stress in each case as dem-
onstrated here may facilitate the design of methods to counteract
replication stress in primary cells or to enhance it in cancer cells to
increase their susceptibility to therapies that target DNA repair.
In proliferating cells, DNA replication precedes mitotic divi-
sion to allow the transmission of genomic information between
generations. The protein machinery responsible for new DNA
synthesis is recruited to thousands of replication origins in the
G1 phase of the cell division cycle. Two replisomes are assem-
bled at each origin that, upon their activation in S phase, move
away from each other, establishing bidirectional replication
forks. The duration of S phase is determined by the number of
active origins and the velocity of replisomes, normally referred
to as “fork speed” or “fork rate” (FR).3 Both parameters can be
analyzed at the single-molecule level using DNA combing or
stretched chromatin fibers in cells sequentially labeled with
nucleotide analogues CldU and IdU (1, 2). Following cell lysis,
labeled DNA molecules are stretched into glass slides, and the
incorporation of analogues is visualized by immunofluores-
cence with separate fluorophores (e.g. red for CldU and green
for IdU) to identify specific replication structures such as ori-
gins, forks, and termination events (Fig. 1A). Although FR is
directly proportional to the length of labeled tracks and can be
quantified using a conversion factor between microscopy
image pixels and DNA length (3), the number of active origins
can only be estimated indirectly. The average distance between
adjacent origins (inter-origin distance, IOD) is frequently used
as a proxy for origin density, as it is inversely proportional to the
density of active origins. However, accurate IOD estimations
require long and stable DNA fibers, and a practical alternative is
to quantify the number of origins activated during the CldU
pulse (referred to as “first-label origins”) relative to a fixed num-
ber of total replication structures, including origins, forks, and
termination events (4). Additional parameters can be analyzed
in DNA fibers, such as fork stalling and restart of DNA synthe-
sis (5), aberrant origin reactivation (6, 7), and resection of newly
synthesized DNA by exonucleases (8). Hence, molecular comb-
ing and stretched DNA fibers have become gold standard tech-
niques to examine DNA replication dynamics.
Replication forks are slowed down and occasionally stopped
as they encounter special DNA structures, transcription pro-
teins, or DNA lesions introduced by radiation or toxic chemicals.
This phenomenon is referred to as “replicative stress” (RS) and is
normally counteracted by mechanisms that protect stalled forks
and promote the restart of DNA synthesis (9–12). Excessive levels
of RS are linked to genomic instability and impinge on many bio-
logical processes, including stem cell fitness, senescence, aging,
and oncogenic transformation (13–18).
At the molecular level, the interpretation of RS phenotypes is
complicated by a marked interdependency between FR and ori-
gin activity. Alterations that slow down forks trigger the activa-
tion of otherwise “dormant” origins as a compensatory mecha-
nism (19, 20), whereas alterations that primarily increase the
number of origins lead to slower forks because the additional
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Figure 1. A CDC7i-based test to separate cause and effect when FR is reduced and origin density is increased. A, DNA replication patterns detected in
stretched DNA fibers labeled with CldU and IdU. B, schematic of an experimental situation leading to simultaneous reduction in FR (arrows) and IOD (dashed
arrows). The use of CDC7i can determine the primary and secondary effects. See text for details. C–E, HeLa cells were treated with HU to reduce FR and IOD.
When indicated, CDC7i was added for 12 h. C, dot plots show the distribution of FR values (from left to right, n  896, 935, 876, and 914). D, estimation of origin
activity calculated as percentage of origin structures (left panel; n  1554, 1518, 1509, and 1511 total structures) or IOD values (right panel; n  142, 157, 104,
and 101). E, representative images of DNA fibers under the conditions described. Scale bar  10 m. F–H, HeLa cells were treated with UCN01 to reduce IOD and
FR. When indicated, CDC7i was added for 4 h. F, distribution of FR values (n  917, 923, 932, and 912). G, percentage of origin structures (left panel; n  1533,
1545, 1526, and 1571 total structures) and distribution of IOD values (right panel; n  152, 153, 152, and 151). H, representative images of DNA fibers under the
conditions described in F and G. Scale bar  10 m. In dot plots, horizontal lines indicate median values. Bar graphs represent mean  S.D. Data were pooled
from three independent experiments.
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replisomes compete for a limited pool of dNTPs and possibly
other factors. Similarly, an increase in the pool of dNTPs accel-
erates fork progression and reduces the likelihood of activation
of neighboring origins, whereas other manipulations that limit
origin activation yield faster forks because of higher dNTP
availability (21–24). In all cases, origin activity and fork speed
influence each other, making it difficult to ascertain the pri-
mary cause of stress. In this study, we have devised and tested
experimental conditions to address this “chicken and egg” cau-
sality problem between fork speed and origin activation, based
on interventions that temporally restrict one of the two param-
eters while still allowing interrogation of the other.
Results and discussion
We first examined the two possible cases that lead to a con-
comitant slowdown of forks (i.e. lower FR) and increase in ori-
gin density (i.e. shorter IOD) in HeLa cells (Fig. 1B). Experimen-
tal conditions were chosen for which the primary effect could
be inferred beforehand. For instance, hydroxyurea (HU) inhib-
its ribonucleotide reductase and reduces the pool of dNTPs,
causing a decrease in FR that subsequently activates dormant
origins (the unlikely alternative would be that HU promotes
origin firing, slowing forks as a consequence). To confirm that
the former interpretation is correct, the effect of HU on FR and
origin activity was tested in the absence or presence of a CDC7
kinase inhibitor (CDC7i). CDC7 kinase activates the MCM
helicase and is necessary for origin firing (25, 26); its depletion
with RNAi has been used to establish the link between replica-
tion initiation and fork progression (4). In our study, the con-
centration of CDC7i was adjusted to reduce origin activity
without inhibiting DNA synthesis altogether; addition of 60 M
CDC7i for 4 –12 h was sufficient to reduce MCM2 phosphory-
lation (Fig. S1A) and restrict origin activation, as indicated by
the lower percentage of first-label origins and increased inter-
origin distances (Fig. S1, B–D). At this CDC7i concentration,
the global effects on DNA synthesis and cell cycle distribution
were modest (Fig. S1, E and F).
Because HU affects fork progression independently of origin
activity, the reduction in FR should be observed regardless of
the presence of CDC7i (Fig. 1B, left branch). If, on the other
hand, the effect of HU depended on the activation of extra ori-
gins, then it would be corrected by CDC7i (Fig. 1B, right
branch). The decrease in FR and concomitant activation of new
origins were readily detected after HU treatment (Fig. 1, C and
D; compare the two leftmost sets of data in each graph). As
anticipated, when HU was combined with CDC7i, FR remained
low despite a strong block in origin activity (Fig. 1, C–E). The
slight increase in FR relative to the HU-only conditions can be
explained as a secondary effect of CDC7i itself following origin
repression (Fig. 1C, compare first and third dot plots; see also
Supp. Fig. 1C).
The opposite situation, i.e. a primary increase in origin activ-
ity, was tested using UCN01, an inhibitor of the checkpoint
kinase CHK1, which promotes promiscuous origin activation
(20, 27, 28). The positive effect of UCN01 on origin activation
was confirmed by the increased percentage of first-label origins
and reduced IOD values, as was the concomitant reduction in
FR (Fig. 1, F and G, the two leftmost sets of data in each graph).
In this case, however, upon addition of CDC7i, the negative
effect of UCN01 on FR was attenuated and reached similar lev-
els as treatment with CDC7i alone (Fig. 1, F–H). This result
confirms that the change in FR is a secondary response that
follows the primary influence of UCN01 on origin activation.
Although RS commonly refers to the slowdown of forks,
there are also experimental scenarios in which forks become
faster while origin activity decreases (i.e. longer IOD; Fig. 2A).
In these cases, in which the use of CDC7i would be redundant
with the defect in origin activity, another intervention was
designed based on the DNA polymerase inhibitor aphidicolin
(APH) to temporarily reduce FR. The rationale is parallel to the
situation described before: if the observed reduction in origin
density is the primary effect and does not depend on fork speed,
then it should be resilient to APH interference. On the contrary,
if it is a secondary response to faster forks, then it would be
corrected by APH (Fig. 2A, compare the left and right branches).
Optimization experiments indicated that a short treatment
with 5 M APH was sufficient to slow down forks (Fig. 2, A–C)
without abolishing DNA synthesis or significantly altering the
cell cycle (Fig. S2, D and E).
To validate the APH test, conditions were found that exerted
a primary influence either on origin density or in FR. For the
first case, cells were treated with CDC7i, which restricts origin
activation and elicits a secondary increase in FR. As anticipated,
origin density was reduced by CDC7i treatment and remained
low even when FR was markedly reduced by APH (Fig. 2, B–D).
The complementary case was tested by supplementing the cell
medium with extra nucleosides to promote faster fork progres-
sion, causing a secondary decrease in origin activation (21, 24,
29). In this case, the effect of nucleosides on origin activity
strictly depended on FR, as it was largely corrected by the addi-
tion of APH (Fig. 2, E–G). These results confirm that the pri-
mary effect of nucleoside addition was to accelerate FR.
Both the CDC7i- and APH-based “causality tests” work
through a temporal disruption in the link between fork rate and
origin activity and allow identification of the primary influence
of different chemical or genetic manipulations on DNA repli-
cation. As proof of concept, we have applied them to a specific
problem arising from our recent research on PrimPol, a protein
with primase and polymerase activities that participates in rep-
licative tolerance to damaged DNA (5, 30 –32). PrimPol down-
regulation in HeLa cells simultaneously reduced FR and IOD
(slower forks, higher origin density), which could be attributed
to a role of PrimPol either at forks or origins (5) (Fig. 3). Accord-
ing to the examples described in Figs. 1 and 2, the test based on
CDC7i should be applied, whereas the test based on APH would
exacerbate the FR phenotype. To demonstrate that this is the
case, both tests were applied to HeLa cells following PrimPol
down-regulation (Fig. 3B). As anticipated, APH acutely
decreased FR and increased origin activity (Fig. 3, C–E),
enhancing the alterations induced by the loss of PrimPol. In this
context, APH does not contribute to discriminate whether
PrimPol primarily affects FR or origin usage. In turn, the use of
CDC7i revealed that the reduction in FR caused by PrimPol
down-regulation was maintained even when extra origins could
not be activated (Fig. 3, F–H). This result indicates that the loss
of PrimPol affects fork progression directly, in line with other
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Figure 2. A test to separate cause and effect when FR is increased and origin density is reduced. A, schematic of an experimental situation leading to
simultaneous increase in FR (arrows) and IOD (dashed arrows). The use of APH allows discrimination of the primary and secondary effects. See text for details.
B–D, HeLa cells were treated with CDC7i for 4 h to increase IOD and FR. When indicated, APH was added for 2 h. B, dot plots showing distribution of FR values
(from left to right, n  889, 881, 905, and 927). C, estimation of origin activity by the percentage of first-label origin structures (left panel; n  1539, 1529, 1529,
and 1527) and distribution of IOD values (right panel; n  153, 147, 157, and 114). D, representative pictures of DNA fibers in HeLa cells treated as described.
Yellow arrowheads point to origins. Scale bar  10 m. E–G, cell medium was supplemented with extra nucleosides for 4 h to increase FR and IOD. When
indicated, APH was added for 2 h. E, distribution of FR values (from left to right, n  929, 921, 915, and 925). F, origin activity estimated as percentage of origin
structures (left panel; n  1549, 1497, 1542, and 1529 total structures) and distribution of IOD values (right panel; n  153, 152, 157, and 156). G, representative
pictures of DNA fibers in HeLa cells treated as described in E and F. Yellow arrowheads point to origins. Scale bar, 10 m. In dot plots, horizontal lines indicate
median values. Bar graphs represent mean  S.D. Data were pooled from three independent experiments.
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Figure 3. The CDC7i test determines that low FR is the primary effect of PrimPol down-regulation. A, schematic of the simultaneous reduction in FR and
IOD (higher origin density) caused by PrimPol down-regulation in HeLa cells (data shown in C–H). The CDC7i test can be applied. B, immunoblots showing the
down-regulation of PrimPol and the effect of CDC7i on MCM2 phosphorylation at Ser-53. MEK2 levels are shown as a loading control. The first two lanes show
serial 2-fold dilutions of the control condition (third lane) for comparison purposes. C–E, the result of applying the APH test. HeLa cells were treated with
doxycycline for 4 days to induce shPrimPol, and 5 M APH was added for 2 h when indicated. C, distribution of FR values (from left to right; n  617, 615, 617,
and 627). D, origin activity as determined by percentage of first-label origin structures (left panel; n  1037, 1037, 1013, and 1044 total structures) and
distribution of IOD values (right panel; n  102, 107, 105, and 103). E, representative images of DNA fibers in HeLa cells treated as in C and D. Scale bar  10 m.
F–H, HeLa cells were treated with doxycycline for 4 days to induce shPrimPol, and 60 M CDC7i was added for 12 h when indicated. F, distribution of FR values
(from left to right, n  934, 979, 901, and 914). G, origin activity determined by percentage of first-label origin structures (left panel; n  1514, 1588, 1641, and
1525 total structures) and distribution of IOD values (right panel; n  141, 157, 37, and 39). H, representative images of DNA fibers in HeLa cells treated as
indicated in F and G. Scale bar  10 m. In the dot plots, median values are indicated by horizontal lines. Bar graphs represent mean  S.D. In C–E, data were
pooled from two independent experiments. In F–H, data were pooled from three independent experiments.
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experiments that support a role for PrimPol in facilitating fork
progression through UV-damaged DNA (5) and G quadruplex
structures in S phase (33).
The CDC7i- and APH-based tests described here are rapid
and straightforward and may be applied to a large variety of
experimental conditions. However, alternative tests may be
designed that follow the same underlying principle, i.e. to coun-
teract one of the two parameters while allowing for the interro-
gation of the other. For instance, in the case of simultaneous
reduction of FR and IOD, CDK inhibitors could be considered
instead of CDC7i when the conditions of the experiment advise
against the inhibition of DDK kinase. In the case of a simulta-
neous increase in FR and IOD, hydroxyurea could substitute for
APH when inhibition of DNA polymerases is to be avoided for
any reason. We encourage researchers to use these types of tests
to determine the primary effect of any chemical or genetic
manipulation on the dynamics of DNA replication. Learning
the precise mechanism underlying RS in each experimental set-
ting will separate events that actually delay fork progression
from those that rather affect origin activity; this information
could then be applied to design strategies to counteract RS in
stem cells, enhancing their long-term functionality (15, 16).
Another promising prospect would be to enhance RS in cancer
cells to increase their sensitivity to therapies targeting DNA
repair pathways or the checkpoint proteins ATR and Chk1
(34 –36). Finally, we hope that these tests may contribute to
further understanding of the impact of oncogene activation on
DNA replication and chromosome fragility (37–40).
Experimental procedures
Cell culture and manipulations
HeLa cells were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum plus penicillin–
streptomycin. To down-regulate PrimPol, a stable HeLa-shPrim-
Pol cell line generated in our laboratory was used (5). Short hairpin
RNA expression was induced with 1 g/ml doxycycline (Sigma)
for 96 h. Hydroxyurea, PHA767491 (CDC7i), APH, and UCN01
were obtained from Sigma. EmbryomaxTM nucleosides were
obtained from Millipore. Unless otherwise indicated, the following
drug concentrations and incubation times were used: 200 M HU
(2 h), 60 M CDC7i (12 h), 10 nM UCN01 (5 h), 5 M APH (2 h), and
150 M nucleosides (4 h).
Single-molecule analysis of DNA replication in stretched DNA
fibers
Cells were pulse-labeled (20 min) with 50 M CldU followed
by 250 M IdU (20 min) prior to cell harvesting and lysis in 0.2
M Tris (pH 7.4), 50 mM EDTA, and 0.5% SDS. Stretched DNA
fibers were prepared as described previously (5). For immuno-
detection of labeled tracks, fibers were incubated with anti-
CldU (rat monoclonal anti-BrdU, Abcam, AB6326), anti-IdU
(mouse monoclonal anti-BrdU, BD Biosciences, 347580), and
anti-single-stranded DNA (Millipore, MAB3034) for 1 h at
room temperature in a humidity chamber. Alexa Fluor-conju-
gated secondary antibodies (Invitrogen/Molecular Probes,
A-11007, A-21121, and A-21241) were used for 30 min at room
temperature. Images were obtained with a DM6000 B Leica
microscope with a HCX PL APO 40 0.75 NA objective. The
conversion factor used was 1 m  2.59 kb (3). Signals were
measured and quantified using ImageJ software (41). For FR,
250 –350 forks (red– green tracks) were measured. For IOD,
15–50 measurements between two adjacent origins on intact
fibers were taken. For origin firing, origins labeled during the
first pulse (green–red– green structures) were quantified as
percentage of all structures containing red (500 total struc-
tures scored in each case).
Immunoblots and antibodies
Whole-cell extracts were prepared by suspension of cells in
Laemmli buffer followed by sonication (3  15 s in a Branson
digital sonifier set at 15% amplitude). SDS-PAGE, protein
transfer to nitrocellulose membranes and immunoblots were
performed using standard protocols. Anti-Mcm2 and anti-
PrimPol have been described previously (5, 39). The following
commercial antibodies were used: anti-MCM2-pS53 (Abcam,
AB70367), anti-MCM2-pS40 (Abcam, AB133243), and anti-
MEK2 (BD Biosciences/Pharmingen, 610236).
Flow cytometry detection of IdU incorporation and DNA content
Cells were pulse-labeled with 250 M IdU for 20 min, col-
lected, and fixed in 70% ethanol. DNA was denatured by incu-
bation in 2 N HCl for 20 min, washed, and incubated with FITC-
conjugated anti-BrdU (BD Biosciences/Pharmingen, 556028)
for 60 min at 37 °C. To monitor DNA content, cells were
stained with 50 g/ml propidium iodide (Sigma) in the pres-
ence of 10 g/ml RNase A (Qiagen). Flow cytometry was per-
formed in a FACSCanto II cytometer (BD Biosciences) and ana-
lyzed with FlowJo 10 (Tree Star).
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29. Malı́nsky, J., Koberna, K., Stanĕk, D., Masata, M., Votruba, I., and Raska, I.
(2001) The supply of exogenous deoxyribonucleotides accelerates the
speed of the replication fork in early S-phase. J. Cell Sci. 114, 747–750
Medline
30. García-Gómez, S., Reyes, A., Martínez-Jiménez, M. I., Chocrón, E. S.,
Mourón, S., Terrados, G., Powell, C., Salido, E., Méndez, J., Holt, I. J., and
Blanco, L. (2013) PrimPol, an archaic primase/polymerase operating in
human cells. Mol. Cell 52, 541–553 CrossRef Medline
31. Bianchi, J., Rudd, S. G., Jozwiakowski, S. K., Bailey, L. J., Soura, V., Taylor,
E., Stevanovic, I., Green, A. J., Stracker, T. H., Lindsay, H. D., and Doherty,
A. J. (2013) PrimPol bypasses UV photoproducts during eukaryotic chro-
mosomal DNA replication. Mol. Cell 52, 566 –573 CrossRef Medline
32. Wan, L., Lou, J., Xia, Y., Su, B., Liu, T., Cui, J., Sun, Y., Lou, H., and Huang,
J. (2013) hPrimpol1/CCDC111 is a human DNA primase-polymerase re-
quired for the maintenance of genome integrity. EMBO Rep. 14,
1104 –1112 CrossRef Medline
33. Schiavone, D., Jozwiakowski, S. K., Romanello, M., Guilbaud, G., Guilliam,
T. A., Bailey, L. J., Sale, J. E., and Doherty, A. J. (2016) PrimPol is required
for replicative tolerance of G quadruplexes in vertebrate cells. Mol. Cell
61, 161–169 CrossRef Medline
34. Toledo, L. I., Murga, M., and Fernandez-Capetillo, O. (2011) Targeting
ATR and Chk1 kinases for cancer treatment: a new model for new (and
old) drugs. Mol. Oncol. 5, 368 –373 CrossRef Medline
35. Toledo, L. I., Murga, M., Zur, R., Soria, R., Rodriguez, A., Martinez, S.,
Oyarzabal, J., Pastor, J., Bischoff, J. R., and Fernandez-Capetillo, O. (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal prop-
erties for cancer-associated mutations. Nat. Struct. Mol. Biol. 18, 721–727
CrossRef Medline
36. Puigvert, J. C., Sanjiv, K., and Helleday, T. (2016) Targeting DNA repair,
DNA metabolism and replication stress as anti-cancer strategies. FEBS J.
283, 232–245 CrossRef Medline
37. Sarni, D., and Kerem, B. (2016) The complex nature of fragile site plasticity
and its importance in cancer. Curr. Opin. Cell Biol. 40, 131–136 CrossRef
Medline
38. Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M.,
Bensimon, A., Zamir, G., Shewach, D. S., and Kerem, B. (2011) Nucleotide
deficiency promotes genomic instability in early stages of cancer develop-
ment. Cell 145, 435– 446 CrossRef Medline
39. Ekholm-Reed, S., Méndez, J., Tedesco, D., Zetterberg, A., Stillman, B., and
Reed, S. I. (2004) Deregulation of cyclin E in human cells interferes with
prereplication complex assembly. J. Cell Biol. 165, 789 – 800 CrossRef
Medline
40. Macheret, M., and Halazonetis, T. D. (2018) Intragenic origins due to
short G1 phases underlie oncogene-induced DNA replication stress. Na-
ture 555, 112–116 CrossRef Medline
41. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods 9, 671– 675 CrossRef
Medline
Cause and effect in replicative stress
J. Biol. Chem. (2018) 293(33) 12855–12861 12861
 at C
entro N











Sara Rodriguez-Acebes, Silvana Mourón and Juan Méndez
replicative stress phenotypes
Uncoupling fork speed and origin activity to identify the primary cause of
doi: 10.1074/jbc.RA118.003740 originally published online June 29, 2018
2018, 293:12855-12861.J. Biol. Chem. 
  
 10.1074/jbc.RA118.003740Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/293/33/12855.full.html#ref-list-1
This article cites 41 references, 15 of which can be accessed free at
 at C
entro N
acional de Investigaciones O
ncológicas on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
